Karyotica Biologicals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 31-07-2024
- Paid Up Capital ₹ 1.60 Cr
as on 31-07-2024
- Company Age 12 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 21.30 Cr
as on 31-07-2024
- Revenue 27.91%
(FY 2023)
- Profit 41.75%
(FY 2023)
- Ebitda 65.07%
(FY 2023)
- Net Worth 75.31%
(FY 2023)
- Total Assets 201.60%
(FY 2023)
About Karyotica Biologicals
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.60 Cr.
The company currently has active open charges totaling ₹21.30 Cr.
Venkata Chunduru, Beeram Chandra, Vijaya Beeram, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232TG2012PTC082062
- Company No.
082062
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jul 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Karyotica Biologicals Private Limited offer?
Karyotica Biologicals Private Limited offers a wide range of products and services, including Bird Food, Poultry & Animal Food, Animal Feed Supplement.
Who are the key members and board of directors at Karyotica Biologicals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkata Chunduru  | Director | 08-Feb-2016 | Current |
| Beeram Chandra | Director | 18-Jul-2012 | Current |
| Vijaya Beeram | Director | 18-Jul-2012 | Current |
| Bapuji Bodapati | Director | 29-Jan-2019 | Current |
Financial Performance and Corporate Structure Insights of Karyotica Biologicals.
Karyotica Biologicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.91% increase. The company also saw a substantial improvement in profitability, with a 41.75% increase in profit. The company's net worth Soared by an impressive increase of 75.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Karyotica Biologicals?
In 2023, Karyotica Biologicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Revelations Biotech Private LimitedActive 16 years 2 monthsVenkata Chunduru, Beeram Chandra and 2 more are mutual person
- Revelations Life Sciences Private LimitedActive 3 years 2 months
Venkata Chunduru and Beeram Chandra are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 May 2023 | ₹5.60 Cr | Open |
Others Creation Date: 02 May 2023 | ₹4.48 Cr | Open |
Hdfc Bank Limited Creation Date: 20 Sep 2022 | ₹4.51 Cr | Open |
How Many Employees Work at Karyotica Biologicals?
Karyotica Biologicals has a workforce of 35 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Karyotica Biologicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Karyotica Biologicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
